POSTERIOR SEGMENT EYE DISORDERS MARKET ANALYSIS

Posterior Segment Eye Disorders MarketSize and Trends

The global posterior segment eye disorders market was valued at US$ 28,360.6 Mn in 2021 and is forecast to reach a value of US$ 39,213.5 Mn by 2028 at a CAGR of 5% between 2022 and 2028. The global posterior segment eye disorders market is experiencing strong growth due to the increase in burden of posterior segment eye disorders and rise in geriatric (aging) population across the globe. Moreover, increase in demand for safe and effective treatments and increase in focus on the development of new therapeutics is expected to boost growth of the market. However, factors such as stringent regulatory framework/policies and lack of primary infrastructure for eye diseases are expected to hamper growth of the market.

Figure 1. Global Posterior Segment Eye Disorders Market Share (%), by Region, 2022

Global Posterior Segment Eye Disorders Market Trends:

Frequent approvals and launches of novel products is a recent trend

Due to rise in burden of posterior segment eye disorders and growing geriatric population across the world, players in the market are focusing on launching and developing novel therapeutics. For instance, the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have approved several drugs/therapeutics to treat posterior segment eye disorders. This in trend is expected to continue over the forecast period, driving the market growth.

Increase in burden of diabetes is another market trend

With the rise in burden of diabetes across the globe, the burden of eye disorders is also increasing with a rapid pace worldwide. Eye disorders, such as diabetic retinopathy, glaucoma, cataracts, and macular edema (which develops along with diabetic retinopathy), affect people with diabetes. This in turn has increased or is increasing the demand for safe & effective treatment, driving the growth of the global posterior segment eye disorders market.